In April 2026, XellSmart officially launches its multicenter Phase II registrational clinical trial of the "Clinical-Grade, Allogeneic, Off-the-Shelf, iPSC-Derived, Dopaminergic Neural Progenitor Cell ...
A new online system delivered through primary schools has been shown to be significantly more effective than standard school ...
Morning Overview on MSN
New sepsis approach filters a harmful blood protein, early results suggest
Every year, sepsis kills roughly 350,000 adults in the United States alone, according to the Centers for Disease Control and ...
A study found that traffic fatalities increased in the United States by nearly 15 percent on the same days as the biggest ...
Analysis of circulating tumor DNA from atebimetinib-treated patients shows acquired MAPK pathway alterations are rare, supporting observed ...
Zhang, J., Zhai, L., Sun, J.D., Yang, C.C., Zhang, Y., Sun, Y.N., Wu, Z.J. and Luo, H.J. (2026) Effect of Glycine Betaine on ...
Morning Overview on MSN
New pancreatic cancer drug shows survival gains in early results
For the roughly 64,000 Americans diagnosed with pancreatic cancer each year, the prognosis remains grim — though regimens ...
The Trump administration’s Department of Government Efficiency (DOGE) did not just cut the Institute of Education Sciences ...
Children with attention deficit hyperactivity disorder (ADHD) may benefit from exercise that challenges both body and mind.
Stop ruminating. Start healing. Discover research-backed writing strategies to transform professional loss into personal ...
Humans have long dreamed of a cure-all.Subscribe to The Post Most newsletter for the most important and interesting stories ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results